Marijuana Stocks News Vinergy Capital, Inc. (VNNYF) Acquires 33% Equity Interest in Cross Border Payment Platform Vinergy Acquires 33% Equity Interest in Cross Border Payment Platform Vinergy Capital,… J. PhillipNov 4, 2021
Marijuana Stocks News Neptune Wellness Solutions Inc. (NEPT) Announces Appointment of KPMG as Auditor Neptune Announces Appointment of KPMG as Auditor Neptune Wellness Solutions Inc. (“Neptune”… Daniel ChaseNov 4, 2021
Marijuana Stocks News Jushi Holdings Inc. (JUSHF) Announces Participation in an Upcoming Event and Conference in November 2021 Jushi Holdings Inc. Announces Participation in an Upcoming Event and Conference in… J. PhillipNov 4, 2021
Marijuana Stocks News Cara Therapeutics, Inc. (CARA) Announces CEO Transition Cara Therapeutics Announces CEO Transition Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical… J. PhillipNov 3, 2021
Marijuana Stocks News Canopy Growth Corporation (CGC) Deep Space Brand Expands Product Offering Canopy Growth’s Deep Space Brand Expands Product Offering with New 10mg THC-infused… J. SamuelNov 3, 2021
Marijuana Stocks News Verano Holdings Corp.(VRNOF) Welcomes Destiny Thompson as Chief People Officer Verano Welcomes Destiny Thompson as Chief People Officer Verano Holdings Corp. (CSE:… J. PhillipNov 3, 2021
Marijuana Stocks News AbbVie Inc. (ABBV) Highlights Innovative Research From Its Rheumatology Portfolio AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021… Brett DavidNov 1, 2021
Marijuana Stocks News Green Thumb Industries Inc. (GTBIF) Announces Conference Participation for November 2021 Green Thumb Industries Announces Conference Participation for November 2021 Green Thumb Industries… J. SamuelNov 1, 2021
Marijuana Stocks News American Premium Water Corporation (HIPH) Identified Among Market Leaders in the Global CBD Beverage Market American Premium Water Corp. (OTC:HIPH) Identified Among Market Leaders in the Global… J. PhillipOct 29, 2021
Marijuana Stocks News AbbVie Inc. (ABBV) Cariprazine (VRAYLAR®) Met Primary Endpoint in Phase 3 Study AbbVie’s Cariprazine (VRAYLAR®) Met Primary Endpoint in Phase 3 Study as an… Daniel ChaseOct 29, 2021